While many states have granted permission for clinical marijuana usage, it stays labeled to be a Routine one drug less than federal standards, lacking acknowledged health care applications and posing a substantial possibility of abuse. In addition, According to the American Culture of Scientific Oncology's 2017 rules, there is inadequate eviden